Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
PaperCitations, authors & open-access status
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 314 citations, 2022 year and bronze oa status.
314
Citations
2022
Year
bronze
OA Status